The private company Nano Medical Technologies (NanoMedTech LLC) was created in December 2009 to carry out advanced nanobioteсhnology research and development aimed at designing innovative drugs and diagnostic systems. A close collaboration between research groups to solve complicated biomedical problems is the unique feature of NanoMedTech.
We focus on interdisciplinary research to better understand the properties of nanoscale materials and various aspects of their interaction with intricate biological systems.
Our objective is invention of novel technologies and methods to diagnose and treat diseases.
We use modern analytical and technical equipment to ensure the high level of research and development.
To scale of technologies of synthesis of nanosized pharmaceutical substances, we use Atlas reactor system (Syrris Ltd., UK) with automatic control of synthesis parameters, which includes temperature-controlled reactor Atlas, volumetric dosing system Atlas with spray pumps, programmable dispenser Lambda Doser for bulk substances (Lambda Laboratory Instruments, CZ), thermostat Ministat 230 (Huber, DE) and nutch filter Pope Scientific (US).
Участие в VIII Международной выставке оборудования и технологий для фармацевтической промышленности PHARMATechExpo и в VIII Международной выставке LABComplEX (Аналитика. Лаборатория. Биотехнология. HI-TECH)
Technological platform for liposomal drug development based on our novel proprietary method and know-how we created versatile technological platform for liposomal drug development which allows us to: - produce liposomes in precise and well controllable manner;
- manipulate composition and size of liposome to optimize the safety and efficacy profile of drug formulations;
- design monodisperse, stable at sto...
Technological platform for liposomal drug development based on our novel proprietary method and know-how we created versatile technological platform for liposomal drug development which allows us to:
- produce liposomes in precise and well controllable manner;